A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one ...
AstraZeneca plc, headquartered in London ... AZN is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. It also boasts a Value Style Score of B thanks to attractive valuation metrics like ...
AstraZeneca has scrapped plans to invest £ ... "All government grant funding has to demonstrate value for the taxpayer and unfortunately, despite extensive work from government officials, it ...
AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...
Science minister Sir Chris Bryant said the Government feels regretful about the plan being ditched and ‘would prefer to have ...
A revival in AstraZeneca Plc shares faces a key test ... The drugmaker’s shares lost more than a quarter of their value in a roughly two-month period last year, amid a Chinese probe into alleged ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback